Press release
Steady Expansion Forecast for Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Projected to Reach $6.09 Billion by 2029
Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market
Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been a significant increase in the size of the adeno-associated virus (avv) vectors in the gene therapy market in recent years. The market, which was worth $2.7 billion in 2024, is predicted to rise to $3.16 billion in 2025, with a compound annual growth rate (CAGR) of 16.7%. The previously observed growth can be attributed to factors such as the increase in gene therapy research investments, the rising usage of gene editing technologies, growth in genetic disorders and unfulfilled medical needs, escalating demand for targeted therapies, and a rise in the collaboration between biotech firms and research institutes.
Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market size for adeno-associated virus (AVV) vectors in gene therapy is projected to experience rapid growth, with an expectation to reach $6.09 billion in 2029 at a compound annual growth rate of 17.6%. This predicted growth in the forecast period can be credited to multiple factors, including the rise in advancements in AAV capsid engineering, an increased focus on precision medicine, amplified investments in the sectors of genetic research and biotechnology, an upswing in the number of clinical trials and approvals for gene therapy, and a growing demand for tailored treatments. Prominent trends in the prediction timeline include the advancements in artificial intelligence usage for AAV capsid engineering, the emergence of hybrid AAV vectors for larger genetic payloads, innovations in AAV targeting through bispecific antibody-mediated, developments in AAV production and purification methodologies that can be scaled up, and the creation of adaptable AAV platforms that can accommodate a variety of viral vectors.
View the full report here:
https://www.thebusinessresearchcompany.com/report/adeno-associated-virus-avv-vectors-in-gene-therapy-global-market-report
What Are the Drivers Transforming the Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market?
The escalating emphasis on therapies centered around genes is predicted to fuel the expansion of the adeno-associated virus (AAV) vectors within the gene therapy market in the future. Gene-centered therapies are procedures that adjust or influence genes to preempt, remedy, or eradicate diseases at the molecular scale. Progressions in genetic examination are responsible for the intensified emphasis on developing gene-based therapies, as they amplify the accuracy and effectivity of gene alteration techniques. Adeno-associated virus (AAV) vectors in gene therapy contribute to the creation of gene-based therapies by securely and effectively transporting curative genes into desired cells, with benefits such as decreased immunogenicity and long-term gene expression. For example, as per IQVIA, an American firm that offers superior analytics and technological resolutions for the life sciences sector, global expenditure on cell and gene therapies was $5.9 billion in 2023, revealing a 38% surge from 2022. Consequently, the amplified emphasis on developing gene-based therapies is fostering the expansion of the adeno-associated virus (AAV) vectors market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24135&type=smp
What Are the Key Trends Driving Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Growth?
Leading corporations in the gene therapy market for adeno-associated virus (AAV) vectors are directing their attention towards advanced innovation, such as customised vector diversity for assay adaptability. This aids in increasing target tissue preciseness, bettering therapeutic efficiency, and speeding up the creation of personalized gene therapies for a range of indications. Customised vector diversity for assay adaptability means utilizing various AAV serotypes or designs to provide support for a plethora of analytical tests and therapeutic uses. For example, in May 2024, a pharmaceutical company based in the US called Charles River Laboratories introduced newer reference materials for both AAV and Lentiviral vectors (LVV). These materials are designed to back the increasing demands of development in cell and gene therapy (CGT). The portfolio enables a more seamless move from primary research to GMP-grade production and helps to standardize methods and enhance regularity in viral vector production. This launch effectively tackles a significant hurdle in escalating CGT programs towards readiness for clinical and commercial purposes.
Which Segments in the Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market Offer the Most Profit Potential?
The adeno-associated virus (avv) vectors in gene therapy market covered in this report is segmented -
1) By Type of Therapy: Gene Augmentation, Immunotherapy, Other Type of Therapy
2) By Type of Gene Delivery Method Used: Ex Vivo, In Vivo
3) By Scale of Operation: Preclinical, Clinical, Commercial
4) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Area
Subsegments:
1) By Gene Augmentation: Monogenic Disorders, Neurological Disorders, Muscular Disorders, Ophthalmological Disorders, Metabolic Disorders
2) By Immunotherapy: Oncology, Infectious Diseases, Autoimmune Disorders, Vaccine Development, T-Cell Engineering
3) By Other Type of Therapy: Gene Editing Support, RNA Interference, Neuroprotection and Neuroregeneration, Anti-Inflammatory Applications, Regenerative Medicine
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24135&type=smp
Which Firms Dominate the Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market by Market Share and Revenue in 2025?
Major companies operating in the adeno-associated virus (AVV) vectors in gene therapy market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Novartis AG, Astellas Gene Therapies Inc., Biogen Inc., Sarepta Therapeutics Inc., Oxford BioMedica plc, Rocket Pharmaceuticals Inc., Aldevron LLC, REGENXBIO Inc., uniQure N.V., Passage Bio Inc., Voyager Therapeutics Inc., Dyno Therapeutics Inc., MeiraGTx Holdings plc, Abeona Therapeutics Inc., 4D Molecular Therapeutics Inc., GenSight Biologics S.A., Taysha Gene Therapies Inc., LogicBio Therapeutics Inc.
Which Regions Offer the Highest Growth Potential in the Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market?
North America was the largest region in the adeno-associated virus (AVV) vectors in gene therapy market in 2024. The regions covered in the adeno-associated virus (AVV) vectors in gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24135
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Steady Expansion Forecast for Adeno-Associated Virus (AVV) Vectors In Gene Therapy Market, Projected to Reach $6.09 Billion by 2029 here
News-ID: 4183945 • Views: …
More Releases from The Business Research Company
Rising Infectious Disease Incidences Drive Growth In The Multivalent Vaccine Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Multivalent Vaccines Market Through 2025?
In the past few years, the market size of multivalent vaccines has experienced substantial growth. A forecast suggests that it will expand from $8.37 billion in 2024 to $9.12 billion in 2025, indicating a compound annual growth…
Pharmacogenetic Testing: Core Growth Enabler in the Impact Of Personalized Medic …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Pharmacogenetic Testing Industry Market Size Be by 2025?
In recent times, the market size for pharmacogenetic testing has experienced significant growth. The market is forecasted to expand from $12.37 billion in 2024 to $14.33 billion in 2025, marking a compound annual growth rate (CAGR) of 15.8%.…
Digestive Enzymes Market Poised to Hit $1.92 Billion by 2029 with Accelerating G …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Digestive Enzymes Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for digestive enzymes has seen significant growth. The industry, which is currently valued at $1.09 billion in 2024, is forecasted to reach $1.19 billion in 2025 with a compound annual growth rate…
Dental Bone Fixation Kits Market on Track for Strong Growth, Estimated to Grow a …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Dental Bone Fixation Kits Market Through 2025?
In the recent past, there has been a robust growth in the market size of dental bone fixation kits. The market is expected to evolve from $1.94 billion in 2024 to $2.09 billion in 2025,…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
